|
Press Releases |
|
 |
|
Wednesday, March 1, 2023 |
|
2023 World Championship F1 Powerboat accomplished, empowers local economy in Lake Toba |
President Joko Widodo (Jokowi) lauded the event of the 2023 World Championship F1 Powerboat (F1H2O) that potentially improved the local economy. more info >> |
|
Friday, February 3, 2023 |
|
Seeing Indonesia's sports tourism development through Lake Toba F1 Powerboat Championship |
In developing its sports tourism potential, Indonesia holds many championships or sports events, and one of the closest is the F1 Powerboat (F1H2O) World Championship in Lake Toba, North Sumatra, on February 24-26, 2023. Lake Toba, one of the most spacious lakes in the world, offers a great destination for athletes to compete, and tourists to enjoy the scenic view. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
富士通、データドリブンで進めるHRBP活動による人的資本経営の実践をまとめた「CHRO Roundtable Report 2025」を発行
Aug 6, 2025 10:30: JST
|
|
|
Fujitsu's CHRO Roundtable Report 2025 highlights data-driven HRBP practices for human capital management
Aug 6, 2025 11:00 JST
|
|
|
TruMerit Launches Global Credential for First-Level, General Nurses
Aug 6, 2025 09:00 HKT/SGT
|
|
|
AITO launches EV Road Tour from Chongqing to Jakarta
Aug 6, 2025 08:00 HKT/SGT
|
|
|
AI+儲能:範式集團與海博思創成立合資公司 市場前景廣闊
Aug 6, 2025 00:08 HKT/SGT
|
|
|
NEFECON(R) Receives NMPA Approval for Production Expansion in China,as Everest Medicines Accelerates Accessibility and Capacity Efforts
Aug 5, 2025 23:22 HKT/SGT
|
|
|
港股機器人板塊升溫 首程控股領跑前線
Aug 5, 2025 23:20 HKT/SGT
|
|
|
Robot Boom in HK: Shoucheng Holdings at the Forefront
Aug 5, 2025 23:18 HKT/SGT
|
|
|
MHI Selected to Enter Next Stage Procurement Process for Australia's New General-Purpose Frigates
Aug 5, 2025 22:02 JST
|
|
|
三菱重工、豪州次期汎用フリゲートの共同開発・生産について発表
Aug 5, 2025 15:00: JST
|
|
|
AI+储能:范式集团与海博思创成立合资公司 市场前景广阔
Aug 5, 2025 14:50 HKT/SGT
|
|
|
港股机器人板块升温 首程控股领跑前线
Aug 5, 2025 14:32 HKT/SGT
|
|
|
Atlas Lithium 的 Neves 项目完成最终可行性研究,预估内部报酬率为 145%,回本期为 11 个月
Aug 5, 2025 13:00 HKT/SGT
|
|
|
Atlas Lithium 的 Neves 項目完成最終可行性研究,預估內部報酬率為 145%,回本期為 11 個月
Aug 5, 2025 13:00 HKT/SGT
|
|
|
全球首個IgA腎病對因治療藥物耐賦康®擴產獲批 雲頂新耀加速提升可及性與產能佈局
Aug 5, 2025 10:21 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|